Specific regulation by endogenous polyamines of translational initiation of S-adenosylmethionine decarboxylase mRNA in Swiss 3T3 fibroblasts.
S-Adenosylmethionine decarboxylase (AdoMetDC) activity was elevated 18.8-fold in Swiss 3T3 fibroblasts which were depleted of cellular polyamines by using the inhibitor difluoromethylornithine (DFMO). Although the cellular level of AdoMetDC mRNA and the half-life of active AdoMetDC protein were also increased (4.3- and 1.5-fold respectively), together they could not account for the magnitude of the increase in AdoMetDC activity. These data suggested that the translation of AdoMetDC mRNA must be increased in the polyamine-depleted cells to account fully for the elevation in activity. The cellular distribution of AdoMetDC mRNA was examined in the polyamine-depleted cells, and it was found almost exclusively associated with large polysomes. In contrast, AdoMetDC mRNA in untreated controls was very heterogeneous, with the proportion associated with monosomes equal to that associated with large polysomes. The shift of the AdoMetDC message into large polysomes occurred within 18 h after addition of DFMO to the cultures and could be reversed by adding exogenous putrescine. The effect of polyamine depletion on AdoMetDC translation was specific, since there was no change in the distribution in polysomes of either actin mRNA or the translationally controlled mRNA encoding ribosomal protein S16 in the DFMO-inhibited cells. Thus the translational efficiency of AdoMetDC mRNA in vivo is regulated either directly or indirectly by the concentration of intracellular polyamines through a mechanism involving translational initiation, which results in a change in the number of ribosomes associated with this mRNA.
White
M W
MW
Department of Biochemistry, University of Washington, Seattle 98195.
Degnin
C
C
Hill
J
J
Morris
D R
DR
D012437:Adenosylmethionine Decarboxylase / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D015317:Biogenic Polyamines / Q000502:physiology*; D002262:Carboxy-Lyases / Q000235:genetics*; D002478:Cells, Cultured; D003600:Cytosol / Q000032:analysis; D000518:Eflornithine / Q000494:pharmacology; D005347:Fibroblasts / Q000032:analysis / Q000201:enzymology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D014176:Protein Biosynthesis / Q000187:drug effects / Q000502:physiology*; D011700:Putrescine / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism*; D012336:RNA, Ribosomal, 16S / Q000378:metabolism
D015317:Biogenic Polyamines; D012333:RNA, Messenger; D012336:RNA, Ribosomal, 16S; D002262:Carboxy-Lyases; D012437:Adenosylmethionine Decarboxylase; D011700:Putrescine; D000518:Eflornithine